C. F. Ramsay (Norwich, United Kingdom), J. Wiggins (Berkshire, United Kingdom)
Formoterol turbuhaler as a rescue therapy was as effective and safe as salbutamol by pMDI and spacer in patients with acute severe asthma
S. Charoenratanakul, W. Boonsawat, C. Pothiratana, K. Sawanyawisuth, T. Seearamrungruang, T. Bengtsson, R. Brander, O. Selroos (Bangkok, Chiang Mai, Thailand; Lund, Sweden)
|  |
Formoterol turbuhaler is effective and safe compared with salbutamol by pMDI and spacer as reliever therapy in patients with acute severe asthma
A. Rubinfeld, R. Scicchitano, A. Hunt, P. J. Thompson, A. Van Nooten, M. Hedlund, A. S. Hörstedt, R. Brander (Melbourne, Adelaide, Elizabeth Vale, Nedlands, Sydney, Australia; Lund, Sweden)
| |
Formoterol (aerolizer) in acute asthma exacerbation
I. A. Stitsenko (St-Petersburg, Russia)
| |
Nebulized therapy in bronchial asthma exacerbation
O. A. Peredelskaya, S. I. Ovtcharenko, N. V. Morozova (Moscow, Russia)
| |
Role of antioxidant and trace element complex in outpatient care of bronchial asthma
N. T. Panina, N. G. Yakovleva, T. V. Kotenko, L. N. Danilov (St-Petersburg, Russia)
| |
The course of asthma during pregnancy
S. Khalilzadeh, M. R. Masjedi, A. H. Prooshani (Tehran, Iran)
| |
Prospective pregnancy outcome data from the START study. On behalf of the START safety committee
| |
Estimation of airway obstruction by auscultation under emergency room condition
J. D. Leuppi, I. Meisinger-Wildeisen, G. Koch, T. Dieterle, B. Martina, M. Tamm, A. P. Perruchoud, B. Leimenstoll (Basel, Switzerland)
| |
Budesonide is retained in the airways longer than mometasone furoate due to the reversible formation of lipophilic budesonide fatty acid esters - significance for asthma therapy
K. Lexmuller, H. Falk Nilsson, R. Brattsand, A. Miller-Larsson (Lund, Sweden)
| |
The use of an asthma diary in the treatment of astmatics in general practice; an evaluation on the first three years after implementation
B. Scheldt, T. Sorensen (Vaerloese, Denmark)
| |
The safety of an asthma diary in the treatment of astmatics in General Practice; an evaluation on the first three years after implementation
T. Sorensen, B. Scheldt (Vaerloese, Denmark)
| |
Severe forms of bronchial asthma in pulmonological department
M. S. Smirnova (Nizhniy Novgorod, Russia)
| |
Gaining the control over severe asthma with the inhalations of very low doses of alkylating drug
K. A. Zykov, V. I. Shevelev, L. Y. Matko, A. I. Veshkina, E. I. Sokolov (Moscow, Russia)
| |
The inhalation of very low doses of alkylating drug as the treatment of severe asthma: five-year results
E. I. Sokolov, K. A. Zykov, A. L. Pukhalsky, V. I. Shevelev (Moscow, Russia)
| |
The prevalence of exercise-induced asthma among symptomatic sportsmen
H. Kaynar, M. Akgun, L. Saglam, A. Mirici, M. Gorguner (Erzurum, Turkey)
| |
Using the Internet as a tool for the management of asthma disease
K. Phanareth, L. Rasmussen, H. Nolte, V. Backer (Copenhagen, Denmark)
| |
Evaluation of dysphonia in asthmatic patients by videostrobolaryngoscopy
M. Polatli, K. K. Metin, M. Yildiz, M. Cam, G. Erpek, O. Cildag (Aydin, Turkey)
| |
Comparative efficacy of different treatment regimens in mild asthmatic patients with hypersensitivity to rye and wheat
L. Mazaeva, E. Shmelev, Z. Aisanov (Moscow, Russia)
| |
Skin side effect pattern in the START study. On behalf of the START safety committee
B. Lindmark, A. Sheffer, A. J. Woolcock, P. Diaz Amor, M. Silverman, F. Radner, W. W. Busse, Y. Z. Chen (Madison, Boston, United States Of America; Camperdown, Australia; Lund, Sweden; Leicester, United Kingdom; Beijing, China)
| |